Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2351 to 2400 of 8905 results

  1. Semaglutide for treating type 2 diabetes in people 10 to 17 years [TSID12249]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  2. Modified release hydrocortisone capsules for treating adrenal insufficiency in people 12 years and over [TSID12254]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  3. Dasiglucagon for treating severe hypoglycaemia caused by type 1 diabetes in people under 6 years [TSID12255]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  4. Ustekinumab for treating moderately to severely active ulcerative colitis in children aged 2 to 17 years [TSID 12128]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  5. Berotralstat for preventing recurrent attacks of hereditary angioedema in children aged 2 to 12 years [TSID 12132]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  6. Lebrikizumab for treating atopic dermatitis in children [TSID12133]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  7. Vedolizumab for treating moderately to severely active ulcerative colitis in people 2 to 17 years [TSID12134]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  8. Lebrikizumab for treating atopic dermatitis in children [TSID 12133_TSID 12135]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  9. Ocrelizumab for treating relapsing–remitting multiple sclerosis in people 10 to 17 years [TSID12164]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  10. Lomitapide for treating homozygous familial hypercholesterolaemia in people 5 to 17 years [TSID 12085]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  11. Eptinezumab for preventing cluster headache attacks TSID 12087

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  12. Selumetinib granules for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children 1 to 6 years [TSID12092]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  13. Avatrombopag for treating primary chronic immune thrombocytopenia in people 1 to 17 years [TSID12109]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  14. Linaclotide acetate for treating functional constipation in people 6 to 17 years [TSID12125]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  15. Clindamycin for treating bacterial vaginosis in females aged 12 and older [TSID 12127]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  16. Cefepime–enmetazobactam for treating hospital-acquired pneumonia, including ventilator-associated pneumonia TS ID 12035

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  17. Telmisartan–amlodipine–indapamide for untreated hypertension TS ID 12034

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  18. Human immunoglobulin with recombinant human hyaluronidase for maintenance treatment of multifocal motor neuropathy in people of any age TSID 12033

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  19. Diclofenac–clotrimazole for Vulvovaginal candidiasis (VVC) [TSID 12053]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  20. Sumatriptan–naproxen for treating migraine-related moderate to severe headache [TS ID 12055]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  21. Abilify MyCite for treating bipolar disorder 1 or schizophrenia [ID3833]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  22. Technologies to improve the detection of endometrial cancer

    Topic prioritisation

    Health technology evaluations
    Topic prioritisation

  23. Tolebrutinib for treating primary progressive multiple sclerosis [ID6574]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  24. HealthVCF for detecting vertebral compression fractures on CT scans MT581 (MIB267)

    Topic prioritisation

    Diagnostics guidance
    Topic prioritisation

  25. MMprofiler for prognostic risk classification in multiple myeloma (MT623) (MIB270)

    Topic prioritisation

    Diagnostics guidance
    Topic prioritisation

  26. Colli-pee void urine collection device (MT628) (MIB273)

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  27. trublood-prostate for triaging and diagnosing people with prostate cancer symptoms (MT604) (MIB268)

    Topic prioritisation

    Diagnostics guidance
    Topic prioritisation

  28. PLASMA system for electrovaporisation of the prostate (MT597) (MIB274)

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  29. MT646 Bardy Carnation Ambulatory Monitor

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  30. CADScor system for ruling out coronary artery disease in people with symptoms of stable coronary artery disease (MT434

    Topic prioritisation

    Diagnostics guidance
    Topic prioritisation

  31. MT650 24/7 EEG SubQ for people with epilepsy

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  32. MT633 FreeO2 Automatic Oxygen Titration

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  33. MT656 Paige Prostate AI system for the detection of prostate cancer

    Topic prioritisation

    Diagnostics guidance
    Topic prioritisation

  34. MT660 CerebAir for monitoring continuous, real-time EEG

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  35. MT658 Quit Genius for Smoking Cessation

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  36. MT684 Smart Peak Flow for monitoring asthma

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  37. The Insides System chyme reinfusion system (MT682)

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  38. TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512)

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  39. Lumella Pre-Eclampsia point-of-care test for assessing pre-eclampsia risk (MT687)

    Topic prioritisation

    Diagnostics guidance
    Topic prioritisation

  40. RespiraSense (MT736)

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  41. Signatera molecular residual disease assay (MT741)

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  42. Stockholm3 blood test for prostate cancer, (MT734),

    Topic prioritisation

    Diagnostics guidance
    Topic prioritisation

  43. PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetes, (MT740)

    Topic prioritisation

    Diagnostics guidance
    Topic prioritisation

  44. Ambu aScope 4 Broncho for routine diagnostic and therapeutic bronchoscopy, (MT158)

    Topic prioritisation

    Diagnostics guidance
    Topic prioritisation

  45. Jada, (MT826)

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  46. Urolon, (MT821)

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  47. BPMpathway for rehabilitation support in joint replacement surgery, (MIB319)

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  48. LIVERFASt for diagnosing and staging liver injury and chronic liver disease, (MT783)

    Topic prioritisation

    Diagnostics guidance
    Topic prioritisation

  49. iQoro neuromuscular training device, (MT809)

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  50. Spectra Optia for plasma exchange, (MT828)

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation